Seeking collaboration- Addressing interventions for neurodegenerative diseases HORIZON-HLTH-2027-02-DISEASE-14-two-stage

R-Evolution Worldwide supports partners in building strong international consortia, identifying complementary expertise and developing competitive proposals aligned with Horizon Europe requirements and deadlines.

Experienced in EU-funded European and Euro-African projects, R-EvoWW provides hands-on support from proposal development and submission through project implementation, reporting and compliance, while fostering an efficient, collaborative and stimulating working environment.

What we offer:

• EU-funded project development, financial management and reporting

• Dissemination, communication and exploitation activities

• International consortium building and project coordination

What we are looking for:

• Clinical neuroscience and expertise in non-rare neurodegenerative diseases

• Innovative pharmacological therapies and early-phase clinical trials (Phase I/II)

• Clinical trial design, patient recruitment and multicentre clinical research

• Complementary non-pharmacological interventions, including cognitive training, rehabilitation and lifestyle-based approaches

• Neuroimaging, biomarkers, omics and mechanisms of disease progression and treatment response

• Digital health technologies, AI and wearable devices for patient monitoring and treatment assessment

• Clinical pharmacology, regulatory affairs and therapeutic development

• Patient organisations and caregiver associations experienced in patient engagement and co-design

• Social sciences and humanities (SSH), quality-of-life assessment and patient-reported outcomes

• Clinical data management, biobanks, patient registries and FAIR data sharing

• Health technology assessment (HTA), health economics, implementation research and market access